Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
1994-10-13
|
pubmed:language |
fin
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0012-7183
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1412
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1727035-Blood Transfusion,
pubmed-meshheading:1727035-Finland,
pubmed-meshheading:1727035-Hepacivirus,
pubmed-meshheading:1727035-Hepatitis, Viral, Human,
pubmed-meshheading:1727035-Hepatitis Antibodies,
pubmed-meshheading:1727035-Hepatitis C Antibodies,
pubmed-meshheading:1727035-Humans,
pubmed-meshheading:1727035-Risk Factors,
pubmed-meshheading:1727035-Tissue Donors
|
pubmed:year |
1990
|
pubmed:articleTitle |
[Risk of hepatitis after blood transfusion in Finland].
|
pubmed:publicationType |
Letter
|